ATE68698T1 - D-cycloserin und deren prodrugs zur verbesserung kognitiver faehigkeiten. - Google Patents

D-cycloserin und deren prodrugs zur verbesserung kognitiver faehigkeiten.

Info

Publication number
ATE68698T1
ATE68698T1 AT88119863T AT88119863T ATE68698T1 AT E68698 T1 ATE68698 T1 AT E68698T1 AT 88119863 T AT88119863 T AT 88119863T AT 88119863 T AT88119863 T AT 88119863T AT E68698 T1 ATE68698 T1 AT E68698T1
Authority
AT
Austria
Prior art keywords
cycloserin
prodrugs
improving cognitive
cognitive skills
skills
Prior art date
Application number
AT88119863T
Other languages
German (de)
English (en)
Inventor
Alex A Cordi
Gail E Handelmann
Joseph B Monahan
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE68698T1 publication Critical patent/ATE68698T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT88119863T 1987-12-01 1988-11-29 D-cycloserin und deren prodrugs zur verbesserung kognitiver faehigkeiten. ATE68698T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/127,121 US4904681A (en) 1987-12-01 1987-12-01 D-cycloserine and its prodrugs as cognitive enhancers
EP88119863A EP0319824B1 (en) 1987-12-01 1988-11-29 D-cycloserine and its prodrugs as cognitive enhancers

Publications (1)

Publication Number Publication Date
ATE68698T1 true ATE68698T1 (de) 1991-11-15

Family

ID=22428413

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88119863T ATE68698T1 (de) 1987-12-01 1988-11-29 D-cycloserin und deren prodrugs zur verbesserung kognitiver faehigkeiten.

Country Status (20)

Country Link
US (1) US4904681A (cg-RX-API-DMAC7.html)
EP (2) EP0319824B1 (cg-RX-API-DMAC7.html)
JP (2) JPH0621065B2 (cg-RX-API-DMAC7.html)
KR (1) KR0134198B1 (cg-RX-API-DMAC7.html)
AT (1) ATE68698T1 (cg-RX-API-DMAC7.html)
AU (4) AU622630B2 (cg-RX-API-DMAC7.html)
CA (1) CA1328617C (cg-RX-API-DMAC7.html)
DE (1) DE3865817D1 (cg-RX-API-DMAC7.html)
DK (1) DK173589B1 (cg-RX-API-DMAC7.html)
ES (1) ES2040314T3 (cg-RX-API-DMAC7.html)
FI (1) FI885559A0 (cg-RX-API-DMAC7.html)
GR (1) GR3003571T3 (cg-RX-API-DMAC7.html)
IE (1) IE61825B1 (cg-RX-API-DMAC7.html)
IL (1) IL88531A (cg-RX-API-DMAC7.html)
NO (1) NO885337D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ227131A (cg-RX-API-DMAC7.html)
PH (1) PH26467A (cg-RX-API-DMAC7.html)
PT (1) PT89109B (cg-RX-API-DMAC7.html)
WO (1) WO1989005144A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA888981B (cg-RX-API-DMAC7.html)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
US5061721A (en) * 1989-03-15 1991-10-29 G. D. Searle & Co. Composition containing d-cycloserine and d-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US5260324A (en) * 1990-02-06 1993-11-09 G. D. Searle & Company Composition containing D-cycloserine and D-alanine for memory and learning enhancement or treatment of a cognitive or psychotic disorder
US5066665A (en) * 1990-05-21 1991-11-19 Warner-Lambert Co. Substituted isoxazolidin-3-ones and derivatives thereof acting at muscarinic receptors
JPH07505908A (ja) * 1992-09-28 1995-06-29 マックセチーニ、マリア　ルイザ Ｎｍｄａ受容体のアロステリックモジュレーター
US5428069A (en) * 1993-01-11 1995-06-27 The United States Of America As Represented By The Department Of Health & Human Services Treating cognition with, aminocyclopropanecarboxylic derivatives
US5523323A (en) * 1993-09-14 1996-06-04 Maccecchini; Maria-Luisa Use of partial agonists of the NMDA receptor to reduce opiate induced tolerance and dependence
NZ260302A (en) * 1994-04-13 1996-05-28 New Zealand Meat Ind Res Inst Treating bait aversion by including substances which disrupt the associative learning process into bait compositions
AU4019395A (en) * 1994-11-23 1996-06-17 G.D. Searle & Co. Use of amino-isoxazolidone compounds for improvement of implicit memory
WO1996015787A1 (en) * 1994-11-23 1996-05-30 G.D. Searle & Co. Use of amino-isoxazolidone compounds for treatment of memory impairment following traumatic brain injury
DE69614835T2 (de) * 1995-02-15 2002-04-25 Annovis, Inc. Alkylcarboxy-aminosäure modulatoren für den kainat-rezeptor
IL124536A (en) * 1995-12-07 2001-03-19 Daniel C Javitt Pharmaceutical compositions containing a glycine uptake antagonist
US6355681B2 (en) * 1995-12-07 2002-03-12 Glytech, Inc. Glycine substitutes and precursors for treating a psychosis
US6361957B1 (en) * 1999-08-03 2002-03-26 Glytech, Inc. Assay for D-serine transport antagonist and use for treating psychosis
FR2742748B1 (fr) * 1995-12-21 1998-01-30 Adir Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui le contiennent
KR100396114B1 (ko) * 1996-10-31 2003-11-20 동아제약 주식회사 D-시클로세린의 제조방법
AU765603C (en) 1998-04-14 2004-08-05 General Hospital Corporation, The Methods for treating neuropsychiatric disorders
DE69930624T2 (de) 1998-06-10 2006-09-14 Meiji Seika Kaisha Ltd. Arzneimittel für hinterstrangataxie und zusammensetzung zur behandlung von hinterstrangataxie
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
JP2004530666A (ja) * 2001-03-29 2004-10-07 エモリー　ユニバーシティ 学習または条件付けのエンハンサーを用いる精神療法の急性薬理学的増強
US20060252761A1 (en) * 2001-03-29 2006-11-09 Michael Davis Augmentation of extinction via administration of sub-antimicrobial doses of D-cycloserine
CN1527813A (zh) * 2001-04-02 2004-09-08 О 作为治疗剂的抗氧化剂硝基氧和亚硝氮碳基
US7160913B2 (en) * 2002-09-13 2007-01-09 Thomas Jefferson University Methods and kit for treating Parkinson's disease
KR20070104480A (ko) 2003-05-27 2007-10-25 포레스트 래보러토리즈, 인코포레이티드 우울증 및 그 밖의 기분장애의 치료를 위한 ｎｍｄａ수용체 길항제 및 선택적 세로토닌 재흡수 억제제의 배합물
EP1660634A4 (en) * 2003-08-08 2009-02-18 Burnham Inst P16-mediated regulation of NMDA receptors
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
PL1874282T3 (pl) 2005-04-06 2011-04-29 Adamas Pharmaceuticals Inc Sposoby i kompozycje do leczenia zaburzeń OUN
WO2010033757A1 (en) 2008-09-18 2010-03-25 Naurex, Inc. Nmda receptor modulators and uses thereof
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
US8951968B2 (en) 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
BR112012020142A2 (pt) 2010-02-11 2020-08-18 Northwestern University moduladores do receptor de nmda com estrutura secundária estabilizada e usos dos mesmos.
KR101692275B1 (ko) 2010-02-11 2017-01-04 노오쓰웨스턴 유니버시티 ２차 구조 안정화된 ｎｍｄａ 수용체 조절제 및 그의 용도
CN105026401A (zh) 2013-01-29 2015-11-04 诺雷克斯股份有限公司 螺-内酰胺nmda受体调节剂及其用途
BR112015018094A2 (pt) 2013-01-29 2017-07-18 Naurex Inc moduladores de receptor nmda de espiro-lactama e usos dos mesmos
JP6419087B2 (ja) 2013-01-29 2018-11-07 アプティニックス インコーポレイテッド スピロラクタム系ｎｍｄａ受容体モジュレーターおよびその使用
MX375286B (es) 2013-01-29 2025-03-06 Aptinyx Inc Moduladores de receptores nmda de espiro-lactama y sus usos.
ES2935352T3 (es) 2013-01-29 2023-03-06 Aptinyx Inc Moduladores de receptores NMDA de espiro-lactama y sus usos
KR102128675B1 (ko) 2016-05-19 2020-06-30 앱티닉스 인크. 스피로-락탐 nmda 수용체 조정제 및 그의 용도
WO2017201285A1 (en) 2016-05-19 2017-11-23 Aptinyx Inc. Spiro-lactam nmda receptor modulators and uses thereof
SG11201900551WA (en) 2016-08-01 2019-02-27 Aptinyx Inc Spiro-lactam nmda receptor modulators and uses thereof
CA3031563C (en) 2016-08-01 2023-12-05 Aptinyx Inc. Spiro-lactam nmda modulators and methods of using same
EA201990424A1 (ru) 2016-08-01 2019-08-30 Аптиникс Инк. Спиролактамовые модуляторы nmda-рецептора и их применение
KR102503590B1 (ko) 2016-08-01 2023-02-24 앱티닉스 인크. 스피로-락탐 nmda 수용체 조정제 및 그의 용도
JP2019527235A (ja) 2016-08-01 2019-09-26 アプティニックス インコーポレイテッド スピロ−ラクタム及びビス−スピロ−ラクタムｎｍｄａ受容体修飾因子及びその使用
EP3427729A1 (en) 2017-07-13 2019-01-16 Paris Sciences et Lettres - Quartier Latin Probenecid for use in treating epileptic diseases, disorders or conditions
SG11202007256PA (en) 2018-01-31 2020-08-28 Aptinyx Inc Spiro-lactam nmda receptor modulators and uses thereof
US12012413B2 (en) 2019-11-11 2024-06-18 Tenacia Biotechnology (Hong Kong) Co., Limited Methods of treating painful diabetic peripheral neuropathy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3010599A1 (de) * 1979-03-22 1980-10-09 Continental Pharma Derivate von glycinamid, deren herstellung und verwendung

Also Published As

Publication number Publication date
CA1328617C (en) 1994-04-19
GR3003571T3 (cg-RX-API-DMAC7.html) 1993-03-16
JPH05201859A (ja) 1993-08-10
FI885559A0 (fi) 1988-11-30
PT89109B (pt) 1993-07-30
KR890009392A (ko) 1989-08-01
AU1083992A (en) 1992-05-07
EP0319824B1 (en) 1991-10-23
DK669088D0 (da) 1988-11-30
AU622630B2 (en) 1992-04-16
KR0134198B1 (ko) 1998-04-21
EP0421997A1 (en) 1991-04-17
IE61825B1 (en) 1994-11-30
JPH0621065B2 (ja) 1994-03-23
EP0319824A1 (en) 1989-06-14
JPH01193220A (ja) 1989-08-03
IL88531A0 (en) 1989-06-30
WO1989005144A1 (en) 1989-06-15
PT89109A (pt) 1989-12-29
DK669088A (da) 1989-06-02
AU2631988A (en) 1989-06-01
NZ227131A (en) 1991-09-25
US4904681A (en) 1990-02-27
PH26467A (en) 1992-07-27
AU7746794A (en) 1995-01-05
IL88531A (en) 1993-02-21
ZA888981B (en) 1990-01-31
DK173589B1 (da) 2001-04-02
NO885337D0 (no) 1988-11-30
DE3865817D1 (cg-RX-API-DMAC7.html) 1991-11-28
ES2040314T3 (es) 1995-04-01
IE883567L (en) 1989-06-01
AU2813089A (en) 1989-07-05

Similar Documents

Publication Publication Date Title
ATE68698T1 (de) D-cycloserin und deren prodrugs zur verbesserung kognitiver faehigkeiten.
DE3779053D1 (cg-RX-API-DMAC7.html)
GR1000023B (el) Καρβαμικος φαινυλεστηρ.
DE69307800D1 (de) Reaktionssystem zur Herstellung von mikrozellularen Elastomeren
FI945442A0 (fi) Uudet 7beta-substituoidut 4-atsa-5alfa-kolestanonit 5alfa-reduktaasi-inhibiittoreina
ATE43834T1 (de) Antimikrobiell wirksame substanzen, ihre herstellung und ihre verwendung.
DE3872063D1 (de) Zusammensetzung mit anregender wirkung fuer die haare.
FI945626A0 (fi) Menetelmä 2,2-difluoriketeenisilyyliasetaalien ja alfa, alfa-difluori-beta-silyylioksi-1,3-dioksolaani-4-propaanihappoestereiden valmistamiseksi
ES2042726T3 (es) Beta-alquilmelatoninas.
DK0476442T3 (da) L-gulono-gamma-lactondehydrogenase
FI102083B1 (fi) Menetelmä L-karnitiinin valmistamiseksi epäjatkuvasti mikrobiologista tietä
GB8714005D0 (en) Organic compounds
IE791378L (en) Alpha-difluoromethyl amino acids
DE3588208D1 (de) Cephalosporinderivative
DE3476065D1 (en) L-arginine isoxicamate
DE3660426D1 (de) Urea acryl derivatives
FR2621212B1 (fr) Perfectionnement aux roues de plombage des semoirs
ES2108165T3 (es) Compuestos policiclicos 31668p y 31668u, un procedimiento para su produccion y su uso como agentes antibioticos o antitumorales.
AU538026B2 (en) Nitrile sulfenyl carbamates
FR2627937B2 (fr) Perfectionnement aux roues de plombage des semoirs
ATE69137T1 (de) Stabilisiertes gossyplure und verfahren zu dessen herstellung.
DK1260222T3 (da) Farmaceutiske præparater indeholdende hidtil ukendte iso-butenyl-substituerede taxaner

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee